As of Nov 27
| +0.07 / +2.19%|
The 1 analysts offering 12-month price forecasts for Immunomedics Inc have a median target of 2.00, with a high estimate of 2.00 and a low estimate of 2.00. The median estimate represents a -38.84% decrease from the last price of 3.27.
The current consensus among 2 polled investment analysts is to Buy stock in Immunomedics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.